Vir Biotechnology (VIR) shares were 58% higher pre-bell Tuesday after the company said late Monday it partnered with Astellas Pharma to jointly advance the development and commercialization of VIR-5500 for the treatment of prostate cancer.
Myriad Genetics (MYGN) stock was up 19%, a day after the company reported higher Q4 adjusted earnings.
Super Group (SGHC) shares were 16% higher after the company reported late Monday higher Q4 revenue.
Thermon Group (THR) stock was up 16% after the company said it has agreed to merge with CECO Environmental (CECO) in a deal worth roughly $2.20 billion.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.